Serological immunoreactivity against colon cancer proteome varies upon disease progression

Lucia De Monte, Francesca Sanvito, Stefano Olivieri, Fiammetta Viganò, Claudio Doglioni, Matteo Frasson, Marco Braga, Angela Bachi, Paolo Dellabona, Maria Pia Protti, Massimo Alessio

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Sera from colon carcinoma patients were used to identify tumor-associated antigens (TAAs) by screening tumor proteome resolved by 2D electrophoresis. A panel of six TAAs eliciting a serological immune response in colorectal cancer was identified, showing a modification in antigen recognition by B cells in patients as a function of colon cancer progression. The expression of these proteins was either confined or increased in tumor as compared to normal mucosa.

Original languageEnglish
Pages (from-to)504-514
Number of pages11
JournalJournal of Proteome Research
Volume7
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Neoplasm Antigens
Proteome
Colonic Neoplasms
Disease Progression
Tumors
Antigens
Electrophoresis
Colorectal Neoplasms
Neoplasms
Colon
Mucous Membrane
B-Lymphocytes
Carcinoma
Serum
Screening
Proteins
Cells

Keywords

  • 2D electrophoresis
  • Colorectal carcinoma
  • Proteomics
  • Tumor-associated antigens

ASJC Scopus subject areas

  • Genetics
  • Biotechnology
  • Biochemistry

Cite this

Serological immunoreactivity against colon cancer proteome varies upon disease progression. / De Monte, Lucia; Sanvito, Francesca; Olivieri, Stefano; Viganò, Fiammetta; Doglioni, Claudio; Frasson, Matteo; Braga, Marco; Bachi, Angela; Dellabona, Paolo; Protti, Maria Pia; Alessio, Massimo.

In: Journal of Proteome Research, Vol. 7, No. 2, 02.2008, p. 504-514.

Research output: Contribution to journalArticle

@article{926b2b3cedc94e00a0da65905aab9202,
title = "Serological immunoreactivity against colon cancer proteome varies upon disease progression",
abstract = "Sera from colon carcinoma patients were used to identify tumor-associated antigens (TAAs) by screening tumor proteome resolved by 2D electrophoresis. A panel of six TAAs eliciting a serological immune response in colorectal cancer was identified, showing a modification in antigen recognition by B cells in patients as a function of colon cancer progression. The expression of these proteins was either confined or increased in tumor as compared to normal mucosa.",
keywords = "2D electrophoresis, Colorectal carcinoma, Proteomics, Tumor-associated antigens",
author = "{De Monte}, Lucia and Francesca Sanvito and Stefano Olivieri and Fiammetta Vigan{\`o} and Claudio Doglioni and Matteo Frasson and Marco Braga and Angela Bachi and Paolo Dellabona and Protti, {Maria Pia} and Massimo Alessio",
year = "2008",
month = "2",
doi = "10.1021/pr070360m",
language = "English",
volume = "7",
pages = "504--514",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Serological immunoreactivity against colon cancer proteome varies upon disease progression

AU - De Monte, Lucia

AU - Sanvito, Francesca

AU - Olivieri, Stefano

AU - Viganò, Fiammetta

AU - Doglioni, Claudio

AU - Frasson, Matteo

AU - Braga, Marco

AU - Bachi, Angela

AU - Dellabona, Paolo

AU - Protti, Maria Pia

AU - Alessio, Massimo

PY - 2008/2

Y1 - 2008/2

N2 - Sera from colon carcinoma patients were used to identify tumor-associated antigens (TAAs) by screening tumor proteome resolved by 2D electrophoresis. A panel of six TAAs eliciting a serological immune response in colorectal cancer was identified, showing a modification in antigen recognition by B cells in patients as a function of colon cancer progression. The expression of these proteins was either confined or increased in tumor as compared to normal mucosa.

AB - Sera from colon carcinoma patients were used to identify tumor-associated antigens (TAAs) by screening tumor proteome resolved by 2D electrophoresis. A panel of six TAAs eliciting a serological immune response in colorectal cancer was identified, showing a modification in antigen recognition by B cells in patients as a function of colon cancer progression. The expression of these proteins was either confined or increased in tumor as compared to normal mucosa.

KW - 2D electrophoresis

KW - Colorectal carcinoma

KW - Proteomics

KW - Tumor-associated antigens

UR - http://www.scopus.com/inward/record.url?scp=39749105485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749105485&partnerID=8YFLogxK

U2 - 10.1021/pr070360m

DO - 10.1021/pr070360m

M3 - Article

C2 - 18179166

AN - SCOPUS:39749105485

VL - 7

SP - 504

EP - 514

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 2

ER -